Development of the Crohn's disease digestive damage score, the Lemann score

B Pariente, J Cosnes, S Danese… - Inflammatory bowel …, 2011 - academic.oup.com
Crohn's disease (CD) is a chronic progressive destructive disease. Currently available
instruments measure disease activity at a specific point in time. An instrument to measure …

Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists

C Stahn, M Löwenberg, DW Hommes… - Molecular and cellular …, 2007 - Elsevier
Glucocorticoids (GC) are the most common used anti-inflammatory and immunosuppressive
drugs in the treatment of rheumatic and other inflammatory diseases. Their therapeutic …

Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands

M Löwenberg, C Stahn, DW Hommes, F Buttgereit - Steroids, 2008 - Elsevier
Glucocorticoids (GCs) are potent anti-inflammatory and immunosuppressant agents.
Unfortunately, they also produce serious side effects that limit their usage. This discrepancy …

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

W Reinisch, WJ Sandborn, DW Hommes, G D'Haens… - Gut, 2011 - gut.bmj.com
Objective The aim of this study was to assess the efficacy and safety of adalimumab (ADA), a
recombinant human monoclonal antibody against tumour necrosis factor α (TNF), for the …

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

M Duijvestein, ACW Vos, H Roelofs, ME Wildenberg… - Gut, 2010 - gut.bmj.com
Background and aim Mesenchymal stromal cells (MSCs) are pluripotent cells that have
immunosuppressive effects both in vitro and in experimental colitis. Promising results of …

A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease

H Braat, P Rottiers, DW Hommes… - Clinical …, 2006 - Elsevier
Background & Aims: The use of living, genetically modified bacteria is an effective approach
for topical delivery of immunomodulatory proteins. This strategy circumvents systemic side …

[HTML][HTML] Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells

AJ van Beelen, Z Zelinkova, EW Taanman-Kueter… - Immunity, 2007 - cell.com
How the development of antibacterial T helper 17 (Th17) cells is selectively promoted by
antigen-presenting dendritic cells (DCs) is unclear. We showed that bacteria, but not viruses …

Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis

M Duijvestein, ME Wildenberg, MM Welling… - Stem …, 2011 - academic.oup.com
Mesenchymal stromal cells (MSCs) are currently under investigation for the treatment of
inflammatory disorders, including Crohn's disease. MSCs are pluripotent cells with …

Allogeneic bone marrow–derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn's disease

I Molendijk, BA Bonsing, H Roelofs, KCMJ Peeters… - Gastroenterology, 2015 - Elsevier
Background & Aims Patients with perianal fistulizing Crohn's disease have a poor prognosis
because these lesions do not heal well. We evaluated the effects of local administration of …

VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis

LJAC Hawinkels, K Zuidwijk, HW Verspaget… - European journal of …, 2008 - Elsevier
Angiogenesis is crucial for the progression of colorectal carcinomas in which the
bioavailability of Vascular Endothelial Growth Factor (VEGF) plays a major role. VEGF …